PATENT CLAIM ANALYSIS

Application Number: 15746617
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "365000"]

Abstract:
Provided is an EP2 agonist having excellent safety. A compound represented by general formula (I) (wherein all symbols are as defined in the description), a salt or N-oxide of the compound, or a solvate or prodrug of the compound or the salt or N-oxide has an EP2 agonist activity and is highly safe, and is therefore useful as a medicine, particularly a therapeutic agent for diseases associated with EP2 receptors, such as immune diseases, allergic diseases, neuronal death, dysmenorrhea, premature birth, miscarriage, baldness, ocular diseases, erectile dysfunction, arthritis, lung injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, bone diseases and cartilage injury.

Claim (Index 3):
The compound according to  claim 1 , a salt or N-oxide of the compound, or a solvate or prodrug of the compound, the salt or the N-oxide, wherein Q represents a bond and at least one of R 3 's represents a halogen atom.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 1.71053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13982052', '15121882', '12944326', '13982001', '15581834']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7609554797228335
- 35 USC 102 Novelty (BERT): 0.60409371480155
- Combined Prediction Score: 0.7452693032307052
- Mean Citation Score: 407.633602
- Max Citation Score: 555.88837
- Similarity Product: 438.6862318809706

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test